[Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors].
Kanyinda-K
J-M
JM
Samalin
E
E
Sebah
H
H
Gallix
B
B
Ychou
M
M
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D018358:Neuroendocrine Tumors / Q000188:drug therapy* / Q000556:secondary*; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin